IAEA/WHO GUIDELINE ON GOOD MANUFACTURING PRACTICES FOR INVESTIGATIONAL RADIOPHARMACEUTICAL PRODUCTS.
Background In view of a rapidly expanding field of molecular imaging and targeted radiopharmaceutical therapy, combined with the absence of a dedicated guidance specific to the manufacture of investigational radiopharmaceuticals used in both early and late clinical trials, the World Health Organizat...
| Publicado en: | WHO Drug Information Vol. 35; no. 3; pp. 612 - 637 |
|---|---|
| Formato: | glossary Journal Article |
| Publicado: |
World Health Organization
2021
|
| Acceso en línea: | Ver este registro en EBSCOhost |